Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik S Mittra

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
AJR. American Journal of Roentgenology|June 28, 2018
Neuroendocrine Tumor Therapy: <sup>177</sup>Lu-DOTATATEErik S Mittra
Radiology|June 24, 2014
Case 207: Hodgkin lymphoma with paraneoplastic hypercalcemic pancreatitisErik S Mittra, Guido Davidzon
Thyroid : Official Journal of the American Thyroid Association|August 19, 2007
Recurrent silent thyroiditis: a report of four patients and review of the literatureErik S Mittra, I Ross McDougall
Molecular Imaging and Biology|May 25, 2010
FDG-PET/CT in cancers of the head and neck: what is the definition of whole body scanning?Andrei Iagaru, Erik S Mittra, Sanjiv Sam Gambhir
PET Clinics|May 10, 2016
PET Imaging of Skull Base NeoplasmsErik S Mittra, Andrei Iagaru, Andrew Quon, et al.
American Journal of Nuclear Medicine and Molecular Imaging|May 15, 2018
Standard OSEM vs. regularized PET image reconstruction: qualitative and quantitative comparison using phantom data and various clinical radiopharmaceuticalsJudit Lantos, Erik S Mittra, Craig S Levin, et al.
American Journal of Physical Anthropology|July 28, 2007
Comparative morphometrics of the primate apical tuftErik S Mittra, Heather F Smith, Pierre Lemelin, et al.
Molecular Imaging and Biology|June 23, 2009
131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphomaAndrei Iagaru, Erik S Mittra, Kristen Ganjoo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2008
Uncommon causes of thyrotoxicosisErik S Mittra, Ryan D Niederkohr, Cesar Rodriguez, et al.
Nuclear Medicine Communications|November 7, 2008
18F-FDG PET/CT evaluation of patients with ovarian carcinomaAndrei H Iagaru, Erik S Mittra, Iain Ross McDougall, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
AJR. American Journal of Roentgenology|June 28, 2018
Neuroendocrine Tumor Therapy: <sup>177</sup>Lu-DOTATATEErik S Mittra
Radiology|June 24, 2014
Case 207: Hodgkin lymphoma with paraneoplastic hypercalcemic pancreatitisErik S Mittra, Guido Davidzon
Thyroid : Official Journal of the American Thyroid Association|August 19, 2007
Recurrent silent thyroiditis: a report of four patients and review of the literatureErik S Mittra, I Ross McDougall
Molecular Imaging and Biology|May 25, 2010
FDG-PET/CT in cancers of the head and neck: what is the definition of whole body scanning?Andrei Iagaru, Erik S Mittra, Sanjiv Sam Gambhir
PET Clinics|May 10, 2016
PET Imaging of Skull Base NeoplasmsErik S Mittra, Andrei Iagaru, Andrew Quon, et al.
American Journal of Nuclear Medicine and Molecular Imaging|May 15, 2018
Standard OSEM vs. regularized PET image reconstruction: qualitative and quantitative comparison using phantom data and various clinical radiopharmaceuticalsJudit Lantos, Erik S Mittra, Craig S Levin, et al.
American Journal of Physical Anthropology|July 28, 2007
Comparative morphometrics of the primate apical tuftErik S Mittra, Heather F Smith, Pierre Lemelin, et al.
Molecular Imaging and Biology|June 23, 2009
131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphomaAndrei Iagaru, Erik S Mittra, Kristen Ganjoo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2008
Uncommon causes of thyrotoxicosisErik S Mittra, Ryan D Niederkohr, Cesar Rodriguez, et al.
Nuclear Medicine Communications|November 7, 2008
18F-FDG PET/CT evaluation of patients with ovarian carcinomaAndrei H Iagaru, Erik S Mittra, Iain Ross McDougall, et al.
Pageof 4